Expression of APM genes (β2M) and tumor immune microenvironment genes (chemokine CCL5) were also higher in patients with CB compared to NCB (unadjusted p = 0.01 and 0.02, respectively) (Fig. 2b). This evidence concerns the gene B2M and neoplasm.